Target intelligence / Profile preview

COXFA4 pseudogene 3 (COXFA4P3)

Target
COXFA4P3
Molecular classification
Pseudogene, Non-coding RNA (potential for transcription, but not protein-coding)
01

Overview

COXFA4P3 is a *pseudogene* classified among noncoding genomic elements related to the NDUFA4 (COXFA4) gene, itself a nuclear-encoded subunit of cytochrome c oxidase (Complex IV) of the mitochondrial respiratory chain[2][4]. Pseudogenes like COXFA4P3 do not code for functional proteins, but recent studies show some pseudogenes can have regulatory roles in gene expression through mechanisms such as acting as decoys for microRNAs or being processed into small RNAs that influence gene silencing pathways[1]. However, no experimental or literature evidence shows that COXFA4P3 specifically acts as a functional regulator, disease marker, or drug target. There is no documentation of drug interaction, mechanism of action, or established biomarker status for COXFA4P3.\n\nIn summary, **COXFA4P3 is not a canonical therapeutic target** and its classification as a pseudogene means it is not generally of direct pharmacological interest, nor is it associated with clinical safety concerns, drug interactions, or defined disease roles. If you intended to catalog functional COX subunits, the *active target would be NDUFA4 (COXFA4), not COXFA4P3* (the pseudogene)[2].

Other names
COXFA4P3
02

Mechanism of action

Not applicable

03

Biological functions

Possible gene regulation by acting as a microRNA decoy or through production of small interfering RNAs (siRNAs)May participate in noncoding RNA regulatory networks, but no COXFA4P3-specific functions are documented
04

Disease associations

Pseudogenes, in general, can be deregulated in cancer, but no specific association with COXFA4P3 is documented

Beyond the preview

Go deeper on COXFA4 pseudogene 3 (COXFA4P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COXFA4 pseudogene 3 (COXFA4P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call